BLTE sets phase-3 trial design in dry AMD: https://www.globenewswire.com/news-release/2022/11/18/2559066/0/en/Belite-Bio-Finalizes-Phase-3-Clinical-Trial-Plans-for-Advanced-Dry-AMD-Treatment-with-Tinlarebant-LBS-008.html